Decay-accelerating factor (CD55) deficiency phenotypes in Japanese

Transfusion Medicine

Volumn 8, Issue 2, 1998, Pages 141-147

  Daniels, G L ^a   Green, C A ^a   Mallinson, G ^a   Okubo, Y ^b   Hori, Y ^b   Kataoka, A ^c   Kaihara, M ^d  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b OSAKA RED CROSS HOSPITAL   (Japan)

^c Shiga Red Cross Blood Center   (Japan)

^d Kitakyusyu Red Cross Blood Center   (Japan)

Author keywords

Blood groups; CD55; Complement regulatory glycoprotein; Decay accelerating factor; Dr(a ) phenotype; Inab phenotype

Indexed keywords

BLOOD LEVEL; COMPLEMENT REGULATORY GLYCOPROTEIN; CROMER SYSTEM BLOOD GROUP ANTIGEN; DECAY ACCELERATING FACTOR; ERYTHROCYTE; HEMAGGLUTINATION INHIBITION; HETEROZYGOSITY; HOMOZYGOSITY; MONOCLONAL ANTIBODY; PHENOTYPE; TITRIMETRY;

ADULT; ANTIGENS, CD55; BLOOD GROUP ANTIGENS; CHILD; ERYTHROCYTES; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 0032104083     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1998.00145.x     Document Type: Article

References (13)

1. Barclay, A.N., Brown, M.H., Law, S.K.A., McKnight, A.J., Tomlinson, M.G. & van der Merwe, P.A. (1997) The Leukocyte Antigen Facts Book, 2nd edn. Academic Press, London.
2. Caras, I.W., Davitz, M.A., Rhee, L., Weddell, G., Martin, D.W. & Nussenzweig, V. (1987) Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature, 325, 545-549.
3. Daniels, G.L. (1980) Blood group antigens of high frequency: a serological and genetical study. PhD thesis, University of London.
4. Daniels, G. (1992) Effect of enzymes on and chemical modification of high frequency red cell antigens. Immunohematology, 8, 53-57.
5. Daniels, G. (1995) Human Blood Groups. Blackwell Science, Oxford, pp. 567-581.
6. Daniels, G.L., Green, C.A., Powell, R.M. & Ward, T. (1998) Hemagglutination-inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion, in press.
7. Daniels, G.L., Tohyama, H. & Uchikawa, M. (1982) A possible null phenotype in the Cromer blood group complex. Transfusion, 22, 362-363.
8. Holguin, M.H., Martin, C.B., Bemshaw, N.J. & Parker, C.J. (1992) Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor. Journal of Immunology, 148, 498-502.
9. a and a family with Dr (a-) in two generations. Transfusion, 27, 64-65.
10. a. Transfusion, 24, 13-15.
11. Levene, C. & Kaufman, S. (1995) Human Blood Groups. Blackwell Science, Oxford, p. 568.
12. Lin, R.C., Herman, J., Henry, L. & Daniels, G.L. (1988) A family showing inheritance of the Inab phenotype. Transfusion, 28, 427-429.
13. Yuan, F.F., Bryant, J.A. & Fletcher, A. (1995) Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells. Immunology and Cell Biology, 73, 66-72.